Silverfin false false 31/05/2025 31/05/2025 01/06/2024 no description of principal activity Alexander Malcolm Ingram 10/06/2004 Ann Moyra Ingram 10/06/2004 SC262000 2025-05-31 SC262000 bus:Director1 2025-05-31 SC262000 bus:Director2 2025-05-31 SC262000 2024-05-31 SC262000 core:CurrentFinancialInstruments 2025-05-31 SC262000 core:CurrentFinancialInstruments 2024-05-31 SC262000 core:Non-currentFinancialInstruments 2025-05-31 SC262000 core:Non-currentFinancialInstruments 2024-05-31 SC262000 2024-06-01 2025-05-31 SC262000 bus:Micro-entities 2024-06-01 2025-05-31 SC262000 bus:FilletedAccounts 2024-06-01 2025-05-31 SC262000 bus:AuditExemptWithAccountantsReport 2024-06-01 2025-05-31 SC262000 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 SC262000 bus:Director1 2024-06-01 2025-05-31 SC262000 bus:Director2 2024-06-01 2025-05-31 SC262000 2023-06-01 2024-05-31 iso4217:GBP xbrli:pure

Company No: SC262000 (Scotland)

# INGRAM'S HOME CURE LIMITED

### UNAUDITED FINANCIAL STATEMENTS
FOR THE FINANCIAL YEAR ENDED 31 MAY 2025
PAGES FOR FILING WITH THE REGISTRAR

INGRAM'S HOME CURE LIMITED

## UNAUDITED FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MAY 2025

Contents

INGRAM'S HOME CURE LIMITED

## COMPANY INFORMATION

FOR THE FINANCIAL YEAR ENDED 31 MAY 2025
INGRAM'S HOME CURE LIMITED

## COMPANY INFORMATION (continued)

FOR THE FINANCIAL YEAR ENDED 31 MAY 2025

DIRECTORS | Alexander Malcolm Ingram
| Ann Moyra Ingram

SECRETARY | Burnett & Reid Llp

REGISTERED OFFICE | Suite A
| 1 Albyn Place
| Aberdeen
| AB10 1BR
| Scotland
| United Kingdom

COMPANY NUMBER | SC262000 (Scotland)

CHARTERED ACCOUNTANTS | Johnston Carmichael LLP
| Axis Business Centre
| Thainstone
| Inverurie
| AB51 5TB

INGRAM'S HOME CURE LIMITED

## BALANCE SHEET

AS AT 31 MAY 2025
INGRAM'S HOME CURE LIMITED

## BALANCE SHEET (continued)

FOR THE FINANCIAL YEAR ENDED 31 MAY 2025

|  | 2025 |  | 2024
|  | £ |  | £
Fixed assets |  | 88,379 |  | 56,495
Current assets |  | 93,593 |  | 88,626
Creditors: amounts falling due within one year |  | ( 44,763) |  | ( 31,788)
Net current assets |  | 48,830 |  | 56,838
Total assets less current liabilities |  | 137,209 |  | 113,333
Creditors: amounts falling due after more than one year |  | ( 31,057) |  | ( 15,678)
Net assets |  | 106,152 |  | 97,655
Capital and reserves |  | 106,152 |  | 97,655

For the financial year ending 31 May 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
- These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
- These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Ingram's Home Cure Limited (registered number: SC262000) were approved and authorised for issue by the Board of Directors on 10 February 2026 and were signed on its behalf by:

Alexander Malcolm Ingram Director |

INGRAM'S HOME CURE LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

FOR THE FINANCIAL YEAR ENDED 31 MAY 2025
INGRAM'S HOME CURE LIMITED

## NOTES TO THE FINANCIAL STATEMENTS (continued)

For the FOR THE FINANCIAL YEAR ENDED 31 MAY 2025

#### 1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in Scotland (Company no. SC262000). The address of its registered office is Suite A, 1 Albyn Place, Aberdeen, AB10 1BR, Scotland, United Kingdom.

#### 2. Employees

| 2025 |  | 2024
| Number |  | Number
Monthly average number of persons employed by the Company during the financial year, including directors | 2 |  | 2